• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.IgA1 免疫复合物来自患有 IgA 肾病的儿科患者,可激活培养的人肾小球系膜细胞。
Nephrol Dial Transplant. 2011 Nov;26(11):3451-7. doi: 10.1093/ndt/gfr448. Epub 2011 Aug 9.
2
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.IgA肾病中含IgA1的免疫复合物对系膜细胞增殖有不同影响。
Kidney Int. 2005 Feb;67(2):504-13. doi: 10.1111/j.1523-1755.2005.67107.x.
3
Interactions of human mesangial cells with IgA and IgA-containing immune complexes.人系膜细胞与IgA及含IgA免疫复合物的相互作用。
Kidney Int. 2002 Aug;62(2):465-75. doi: 10.1046/j.1523-1755.2002.00477.x.
4
The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.IgA1 免疫复合物介导的系膜细胞 MAPK/ERK 激酶通路的激活与 IgA 肾病的肾小球损伤有关。
Kidney Int. 2012 Dec;82(12):1284-96. doi: 10.1038/ki.2012.192. Epub 2012 Sep 5.
5
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.来自IgA肾病患者的系膜细胞对半乳糖缺陷型IgA1的易感性增加。
BMC Nephrol. 2016 Apr 5;17:40. doi: 10.1186/s12882-016-0251-5.
6
IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.IgA肾病和过敏性紫癜性肾炎:IgA1糖基化异常、含IgA1免疫复合物的形成以及系膜细胞的激活。
Contrib Nephrol. 2007;157:134-8. doi: 10.1159/000102455.
7
Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.IgA肾病患者的IgA1对人肾小球系膜细胞的结合能力及病理生理效应
Clin Exp Immunol. 2004 Apr;136(1):168-75. doi: 10.1111/j.1365-2249.2004.02408.x.
8
Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.IgA肾病中IgA1的异常糖基化和抗聚糖抗体:黏膜免疫系统的作用
Adv Otorhinolaryngol. 2011;72:60-3. doi: 10.1159/000324607. Epub 2011 Aug 18.
9
Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.IgG 的唾液酸化可抑制缺乏半乳糖的 IgA1 免疫复合物的形成,并保护 IgA 肾病中的系膜细胞免受损伤。
BMC Nephrol. 2022 Jan 11;23(1):25. doi: 10.1186/s12882-021-02657-8.
10
Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.聚糖特异性IgG抗体在IgA肾病中的致病作用。
BMC Nephrol. 2017 Sep 29;18(1):301. doi: 10.1186/s12882-017-0722-3.

引用本文的文献

1
Molecular mechanisms and therapeutic interventions in acute kidney injury: a literature review.急性肾损伤的分子机制与治疗干预:文献综述
BMC Nephrol. 2025 Mar 22;26(1):144. doi: 10.1186/s12882-025-04077-4.
2
Emerging Biochemical and Immunologic Mechanisms in the Pathogenesis of IgA Nephropathy.IgA肾病发病机制中的新兴生化和免疫机制
Semin Nephrol. 2024 Sep;44(5):151565. doi: 10.1016/j.semnephrol.2025.151565. Epub 2025 Mar 13.
3
IgA Nephropathy: Emerging Mechanisms of Disease.IgA肾病:疾病的新发病机制
Indian J Nephrol. 2024 Jul-Aug;34(4):297-309. doi: 10.25259/ijn_425_23. Epub 2024 Jun 24.
4
O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.IgA1 的 O-糖基化与自身免疫性疾病 IgA 肾病的发病机制。
Glycobiology. 2024 Sep 30;34(11). doi: 10.1093/glycob/cwae060.
5
Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.斯巴森坦可改善 IgA 肾病小鼠模型中由 IgA1-IgG 免疫复合物引起的肾小球细胞过度增生和炎症基因网络。
Am J Physiol Renal Physiol. 2024 May 1;326(5):F862-F875. doi: 10.1152/ajprenal.00253.2023. Epub 2024 Mar 21.
6
Deciphering roles of protein post-translational modifications in IgA nephropathy progression and potential therapy.解析 IgA 肾病进展中蛋白质翻译后修饰的作用及潜在治疗靶点。
Aging (Albany NY). 2024 Jan 3;16(1):964-982. doi: 10.18632/aging.205406.
7
Causal relationships between circulating inflammatory factors and IgA vasculitis: a bidirectional Mendelian randomization study.循环炎症因子与 IgA 血管炎之间的因果关系:一项双向孟德尔随机化研究。
Front Immunol. 2023 Sep 11;14:1248325. doi: 10.3389/fimmu.2023.1248325. eCollection 2023.
8
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.当前对补体蛋白作为治疗免疫球蛋白 A 肾病的治疗靶点的理解。
Drugs. 2023 Nov;83(16):1475-1499. doi: 10.1007/s40265-023-01940-2. Epub 2023 Sep 25.
9
Factors associated with the progression of mesangial lesions in IgA nephropathy: A comparative analysis of renal re-biopsies.与 IgA 肾病系膜病变进展相关的因素:肾再活检的对比分析。
Front Endocrinol (Lausanne). 2022 Nov 21;13:1004289. doi: 10.3389/fendo.2022.1004289. eCollection 2022.
10
Racial heterogeneity of IgA1 hinge-region -glycoforms in patients with IgA nephropathy.IgA肾病患者中IgA1铰链区糖型的种族异质性。
iScience. 2022 Sep 27;25(11):105223. doi: 10.1016/j.isci.2022.105223. eCollection 2022 Nov 18.

本文引用的文献

1
Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes.异常糖基化的 IgA1 诱导肾小球系膜细胞产生血小板激活因子,介导培养的足细胞中nephrin 的丢失。
Kidney Int. 2010 Mar;77(5):417-27. doi: 10.1038/ki.2009.473. Epub 2009 Dec 16.
2
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.IgA肾病患者中糖基化异常的IgA1可被具有有限异质性的IgG抗体识别。
J Clin Invest. 2009 Jun;119(6):1668-77. doi: 10.1172/JCI38468. Epub 2009 May 26.
3
Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy.IgA 肾病中系膜源性细胞因子诱导的足细胞损伤。
Nephrol Dial Transplant. 2009 Jan;24(1):62-72. doi: 10.1093/ndt/gfn441. Epub 2008 Aug 6.
4
IgA nephropathy and Henoch-Schönlein purpura nephritis.IgA肾病和过敏性紫癜性肾炎。
Curr Opin Pediatr. 2008 Apr;20(2):163-70. doi: 10.1097/MOP.0b013e3282f4308b.
5
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.来自IgA肾病患者的分泌IgA1的细胞系产生异常糖基化的IgA1。
J Clin Invest. 2008 Feb;118(2):629-39. doi: 10.1172/JCI33189.
6
Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.聚合免疫球蛋白A1与转铁蛋白受体的结合:IgA肾病中存在涉及受体表达增加和系膜细胞增殖的正反馈回路的证据。
J Am Soc Nephrol. 2005 Sep;16(9):2667-76. doi: 10.1681/ASN.2004111006. Epub 2005 Jun 29.
7
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.IgA肾病中含IgA1的免疫复合物对系膜细胞增殖有不同影响。
Kidney Int. 2005 Feb;67(2):504-13. doi: 10.1111/j.1523-1755.2005.67107.x.
8
IgA nephropathy: an update.IgA肾病:最新进展
Curr Opin Nephrol Hypertens. 2004 Mar;13(2):171-9. doi: 10.1097/00041552-200403000-00005.
9
Aberrant glycosylation in IgA nephropathy (IgAN).IgA肾病(IgAN)中的异常糖基化。
Kidney Int. 2004 May;65(5):1544-7. doi: 10.1111/j.1523-1755.2004.05407.x.
10
Interactions of human mesangial cells with IgA and IgA-containing immune complexes.人系膜细胞与IgA及含IgA免疫复合物的相互作用。
Kidney Int. 2002 Aug;62(2):465-75. doi: 10.1046/j.1523-1755.2002.00477.x.

IgA1 免疫复合物来自患有 IgA 肾病的儿科患者,可激活培养的人肾小球系膜细胞。

IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.

机构信息

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

Nephrol Dial Transplant. 2011 Nov;26(11):3451-7. doi: 10.1093/ndt/gfr448. Epub 2011 Aug 9.

DOI:10.1093/ndt/gfr448
PMID:21828345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3203630/
Abstract

BACKGROUND

Circulating immune complexes (CIC) containing galactose (Gal)-deficient IgA1 from adults with IgA nephropathy (IgAN) induce proliferation of cultured mesangial cells, but activities of CIC from pediatric patients with the disease have not been studied.

METHODS

CIC of different sizes were isolated from sera of pediatric and adult IgAN patients and their effects on cultured human mesangial cells (MC) were assessed by measuring cellular proliferation, expression of IL-6 and IL-8 and laminin and phosphotyrosine signaling.

RESULTS

Large CIC from pediatric IgAN patients (>800 kDa) containing Gal-deficient IgA1 stimulated cellular proliferation, whereas in some patients, smaller CIC were inhibitory. Addition of stimulatory and inhibitory CIC to MC differentially altered phosphorylation patterns of three major tyrosine-phosphorylated proteins of molecular mass 37, 60 and 115 kDa. The stimulatory CIC transiently increased tyrosine-phosphorylation of the 37-kDa protein and decreased phosphorylation of the other two proteins, whereas the inhibitory CIC increased phosphorylation of all three proteins. Furthermore, we investigated the influence of IgA1-containing CIC from sera of children with IgAN with clinically active disease (i.e., abnormal urinalysis and/or serum creatinine concentration) or inactive disease (i.e., normal urinalysis and serum creatinine concentration) on the expression of IL-6 and IL-8 genes by mesangial cells. Real-time reverse transcription-polymerase chain reaction results showed that the CIC from a patient with active disease stimulated MC to express the two cytokine genes at higher levels than did the CIC from a patient with inactive disease. Moreover, stimulatory CIC increased production of the extracellular matrix protein laminin.

CONCLUSION

These data indicate that sera of pediatric IgAN patients contain biologically active CIC with Gal-deficient IgA1.

摘要

背景

含有 IgA 肾病(IgAN)成人中缺乏半乳糖的循环免疫复合物(CIC)可诱导培养的系膜细胞增殖,但尚未研究来自小儿 IgAN 患者的 CIC 的活性。

方法

从小儿和成人 IgAN 患者的血清中分离不同大小的 CIC,并通过测量细胞增殖、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)以及层粘连蛋白和磷酸酪氨酸信号的表达来评估它们对培养的人系膜细胞(MC)的影响。

结果

来自小儿 IgAN 患者(>800 kDa)的大 CIC 含有缺乏半乳糖的 IgA1,可刺激细胞增殖,而在一些患者中,较小的 CIC 具有抑制作用。刺激和抑制性 CIC 分别添加到 MC 中可改变三个主要酪氨酸磷酸化蛋白的磷酸化模式,其分子量分别为 37、60 和 115 kDa。刺激性 CIC 可短暂增加 37 kDa 蛋白的酪氨酸磷酸化,降低另外两种蛋白的磷酸化,而抑制性 CIC 则增加所有三种蛋白的磷酸化。此外,我们研究了来自患有 IgAN 且具有临床活动性疾病(即异常尿分析和/或血清肌酐浓度)或非活动性疾病(即正常尿分析和血清肌酐浓度)的儿童的 IgA1 含量的 CIC 对系膜细胞中 IL-6 和 IL-8 基因表达的影响。实时逆转录-聚合酶链反应结果表明,来自活动性疾病患者的 CIC 刺激 MC 以更高的水平表达两种细胞因子基因,而来自非活动性疾病患者的 CIC 则没有。此外,刺激性 CIC 增加了细胞外基质蛋白层粘连蛋白的产生。

结论

这些数据表明,小儿 IgAN 患者的血清中含有具有半乳糖缺陷 IgA1 的生物活性 CIC。